EarlySense signs Welch Allyn US distribution deal

By GLOBES CORRESPONDENT
February 5, 2013 05:26

EarlySense CEO Avner Halperin: We estimate the market potential for the patient monitoring system at $4-5 billion.




Dollar bills.

Dollar bills 150. (photo credit: Steve Marcus / Reuters)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 9 - 17
    Beer Sheva
    12 - 16
    Tel Aviv - Yafo
  • 6 - 12
    Jerusalem
    9 - 14
    Haifa
  • 11 - 22
    Elat
    12 - 16
    Tiberias